Copanlisib and Impurities
Copanlisib dihydrochloride
CAS:1402152-13-9
Copanlisib dihydrochloride: ATP-competitive PI3K inhibitor, potent for PI3Kα/δ/β/γ, antitumor, 2000x selectivity over other kinases except …
Formula:
C23H30Cl2N8O4
Purity:
99.05%
Color and Shape:
Solid
Molecular weight:
553.44
Ref: TM-T14998
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 123.00 € | ||
| 50mg | 207.00 € | ||
| 100mg | 346.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-C-234003
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Copanlisib
CAS:1032568-63-0
Copanlisib (BAY 80-6946), a PI3K inhibitor, may block tumor growth and improve cancer treatment efficacy.
Formula:
C23H28N8O4
Purity:
99.02% - 99.88%
Color and Shape:
Solid
Molecular weight:
480.52
Ref: TM-T6322
| 2mg | 38.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 123.00 € | ||
| 50mg | 208.00 € | ||
| 100mg | 348.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-C-234002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-C-234001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
